[go: up one dir, main page]

BR9708655A - Derivados de isatina como inibidores de acetilcolinesterase e analgésicos - Google Patents

Derivados de isatina como inibidores de acetilcolinesterase e analgésicos

Info

Publication number
BR9708655A
BR9708655A BR9708655A BR9708655A BR9708655A BR 9708655 A BR9708655 A BR 9708655A BR 9708655 A BR9708655 A BR 9708655A BR 9708655 A BR9708655 A BR 9708655A BR 9708655 A BR9708655 A BR 9708655A
Authority
BR
Brazil
Prior art keywords
analgesics
acetylcholinesterase inhibitors
isatin derivatives
isatin
derivatives
Prior art date
Application number
BR9708655A
Other languages
English (en)
Inventor
Stephen J Shimshock
Abdul E Mutlib
Susan M Chesson
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of BR9708655A publication Critical patent/BR9708655A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BR9708655A 1996-04-12 1997-03-07 Derivados de isatina como inibidores de acetilcolinesterase e analgésicos BR9708655A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63187096A 1996-04-12 1996-04-12
PCT/US1997/003598 WO1997038993A1 (en) 1996-04-12 1997-03-07 Isatin derivatives as acetylcholinesterase inhibitors and analgesics

Publications (1)

Publication Number Publication Date
BR9708655A true BR9708655A (pt) 1999-08-03

Family

ID=24533114

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708655A BR9708655A (pt) 1996-04-12 1997-03-07 Derivados de isatina como inibidores de acetilcolinesterase e analgésicos

Country Status (19)

Country Link
EP (1) EP0892796B1 (pt)
JP (1) JP4109718B2 (pt)
KR (1) KR20000005379A (pt)
CN (1) CN1215399A (pt)
AR (1) AR006606A1 (pt)
AT (1) ATE207483T1 (pt)
BR (1) BR9708655A (pt)
CA (1) CA2252039C (pt)
DE (1) DE69707659T2 (pt)
DK (1) DK0892796T3 (pt)
ES (1) ES2165586T3 (pt)
GR (1) GR3037006T3 (pt)
HU (1) HUP9903473A3 (pt)
IL (1) IL126308A0 (pt)
NO (1) NO984740D0 (pt)
PT (1) PT892796E (pt)
TW (1) TW426678B (pt)
WO (1) WO1997038993A1 (pt)
ZA (1) ZA972990B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
JP5379692B2 (ja) 2006-11-09 2013-12-25 プロビオドルグ エージー 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての3−ヒドロキシ−1,5−ジヒドロ−ピロール−2−オン誘導体
EP2091948B1 (en) 2006-11-30 2012-04-18 Probiodrug AG Novel inhibitors of glutaminyl cyclase
EP2117540A1 (en) 2007-03-01 2009-11-18 Probiodrug AG New use of glutaminyl cyclase inhibitors
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
WO2011029920A1 (en) 2009-09-11 2011-03-17 Probiodrug Ag Heterocylcic derivatives as inhibitors of glutaminyl cyclase
EA202092673A3 (ru) 2010-02-09 2021-05-31 Дзе Джонс Хопкинс Юниверсити Способы и композиции для улучшения когнитивной функции
WO2011101774A1 (en) 2010-02-16 2011-08-25 Pfizer Inc. (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors
WO2011107530A2 (en) 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
ES2481823T3 (es) 2010-03-10 2014-07-31 Probiodrug Ag Inhibidores heterocíclicos de glutaminil ciclasa (QC, EC 2.3.2.5)
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
WO2014090929A1 (en) 2012-12-13 2014-06-19 H. Lundbeck A/S Compositions comprising vortioxetine and donepezil
JP6433482B2 (ja) 2013-03-15 2018-12-05 エージンバイオ, インコーポレイテッド 認知機能を改善するための方法および組成物
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
WO2016179157A1 (en) * 2015-05-05 2016-11-10 Carafe Drug Innovation, Llc Substituted 5-hydroxyoxindoles and their use as analgesics and fever reducers
BR112017025031B1 (pt) 2015-05-22 2023-03-21 Agenebio, Inc Composições farmacêuticas de liberação prolongada de levetiracetam
EP3461819B1 (en) 2017-09-29 2020-05-27 Probiodrug AG Inhibitors of glutaminyl cyclase
CA3237487A1 (en) * 2021-11-05 2023-05-11 The Regents Of The University Of California Alpha-2a adrenergic receptor modulators and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994472A (en) * 1989-08-02 1991-02-19 Hoechst-Roussel Pharmaceuticals Incorporated 1-(pyridinylamino)-2-pyrrolidinones as pain relievers
US5296488A (en) * 1989-08-02 1994-03-22 Hoechst-Roussel Pharmaceuticals Inc. Method of using 2,3-dihydro-1-(pyridinylamino)-indoles as anticonvulsants and for the enhancement of memory
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones

Also Published As

Publication number Publication date
TW426678B (en) 2001-03-21
AR006606A1 (es) 1999-09-08
EP0892796B1 (en) 2001-10-24
GR3037006T3 (en) 2002-01-31
HUP9903473A2 (hu) 2000-05-28
CN1215399A (zh) 1999-04-28
PT892796E (pt) 2002-03-28
KR20000005379A (en) 2000-01-25
JP4109718B2 (ja) 2008-07-02
NO984740L (no) 1998-10-09
AU716997B2 (en) 2000-03-16
DE69707659T2 (de) 2002-05-08
WO1997038993A1 (en) 1997-10-23
IL126308A0 (en) 1999-05-09
HUP9903473A3 (en) 2000-09-28
CA2252039A1 (en) 1997-10-23
NO984740D0 (no) 1998-10-09
DK0892796T3 (da) 2001-11-19
ZA972990B (en) 1997-11-03
EP0892796A1 (en) 1999-01-27
JP2001508400A (ja) 2001-06-26
AU2072597A (en) 1997-11-07
ES2165586T3 (es) 2002-03-16
ATE207483T1 (de) 2001-11-15
DE69707659D1 (de) 2001-11-29
CA2252039C (en) 2002-12-24

Similar Documents

Publication Publication Date Title
BR9708655A (pt) Derivados de isatina como inibidores de acetilcolinesterase e analgésicos
DE69723446D1 (de) Oxindole derivate
PT946512E (pt) Derivados de 6-fenilpiridil-2-amina uteis como inibidores de nos
BR9709105A (pt) Sulfonamidas de quinolina como inibidoras de tnf e como inobidoras de pde-iv
HUP9901155A3 (en) Quinazoline derivatives as vegf inhibitors
PT1042287E (pt) Derivados de indole como inibidores do factor xa
ID17948A (id) Piridine bersumbu heterosiklik
DE69729947D1 (de) N-substituierte 2-cyanopyrrolidine
BR9700850A (pt) Derivados de quinazolina substituídos
BR9710606A (pt) Barreira acÚstica e conjunto de barreira acÚstica
DE69903143D1 (de) Chromanon und thiochromanon derivate
NO992104D0 (no) Isokinoloner
DE59708262D1 (de) Distanzschutzverfahren
DE50001834D1 (de) Vliesanlage und Betriebsverfahren
DE59914173D1 (de) Zündanlage und zündsteuerverfahren
DE69634991D1 (de) Elektrotherapiegerät
DK0912553T3 (da) Benzo[g]quinolin-derivater
EE04494B1 (et) 1-oksa-, asa- ja tianaftaleen-2-oon biseetrid fosfolambaani inhibiitoritena
ES1034733Y (es) Cenicero perfeccionado
NO970431D0 (no) Tetrahydroisokinolin-derivater
DE69715979D1 (de) Chinolinderivate und ihre Anwendung
ATA18796A (de) Sicherheitshaus
SI0892796T1 (en) Isatin derivatives as acetylcholinesterase inhibitors and analgesics
FI964569L (fi) Lähetinyksikkö ja tukiasema
UA22363A (uk) Вмоhтоваhий диhамічhий захист

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements